Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period from May 1, 2017, to October 31, 2017. The document serves as a Block Listing Six Monthly Return, detailing the status of various employee share option and savings schemes. It does not contain general business operations updates or financial performance data.
Key Financial Metrics
The filing text does not provide values for revenue, profit, cash flow, margins, debt, or liquidity. The document exclusively reports on the number of securities available under specific equity compensation plans.
Material Changes in Equity Schemes
During the reporting period, no increases were applied for in any of the listed schemes. The following schemes saw securities issued or allotted:
- GlaxoSmithKline Share Option Plan - Ordinary Shares: 543,609 securities issued.
- GlaxoSmithKline Share Option Plan - ADS: 611,414 securities issued.
- GlaxoSmithKline plc Share Save Plan 2012: 93,255 securities issued.
- GlaxoSmithKline plc 2009 Deferred Annual Bonus Plan: 989 securities issued.
The following schemes reported zero securities issued during the period:
- Glaxo Wellcome UK Share Option Scheme
- Glaxo Wellcome International Share Option Scheme
- Glaxo Wellcome 1999 Share Option Plan
- SmithKline Beecham 1989 Executive Share Option Plan (Approved - Ordinary Shares)
- SmithKline Beecham 1989 Executive Share Option Plan (Unapproved - ADS)
- SmithKline Beecham 1989 Executive Share Option Plan (Unapproved - Ordinary)
Outlook, Risks, and Management Commentary
The filing text does not provide guidance, outlook, management commentary, risks, contingencies, or unusual items. The document is a regulatory compliance report regarding share scheme balances.
Investor Verification Points
- Verify the total reduction in unallotted securities across all schemes to assess potential dilution impact.
- Confirm the remaining balance of unallotted securities for the primary schemes (Ordinary Shares and ADS) to understand future issuance capacity.
- Note that no new shares were added to the block listing schemes during this six-month period.